8-K/AThe WireRoutine
Shareholder Vote
Filed Dec 19, 2017 · 8y ago · Accession 0001193125-17-373608
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- GALECTIN THERAPEUTICS INC
- Ticker
- GALT
- CIK
- 1133416
- Form type
- 8-K/A
- Filing date
- Dec 19, 2017
- Report date
- Dec 14, 2017
- Document
- d466338d8ka.htm
- Size
- 33 KB